sentences:  It is marketed in a number of European countries.Dapagliflozin was approved for medical use in the United States in January 2014.In 2020, the U.S. Food and Drug Administration (FDA) expanded the indications for dapagliflozin to include treatment for adults with heart failure with reduced ejection fraction to reduce the risk of cardiovascular death and hospitalization for heart failure.